Moderna to raise up to $2.3 billion via convertible notes, indicating a push toward oncology growth while using proceeds to repay debt
The company said it plans to sell $2 billion in convertible notes, with an option to increase the offering. Traders and retail investors questioned the timing and structure of the deal.